COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 634: Articles 6331-6340  | Next

Deep reinforcement learning framework for controlling infectious disease outbreaks in the context of multi-jurisdictions
khatami, S. N., Gopalappa, C.
10.1101/2022.10.18.22281063 — Posted: 2022-10-21
Parental Preferences and Reasons for COVID-19 Vaccination Among Their Children
Sehgal, N., Rader, B., Gertz, A., Astley, C. M., Brownstein, J. S.
10.1101/2022.10.20.22281313 — Posted: 2022-10-21
Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the Netherlands
Backer, J. A., Bogaardt, L., Beutels, P., Coletti, P., Edmunds, J., Gimma, A., van Hagen, C. C. E., Hens, N., Jarvis, C. I., Vos, E. R. A., Wambua, J., Wong, D., van Zandvoort, K., Wallinga, J.
10.1101/2022.10.19.22281248 — Posted: 2022-10-21
Investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD Cohort study: methodology and cohort profile
Azeez, R., Lotoski, L., Dubeau, A., Rodriguez, N., Reyna, M. E., Freitas, T., Goguen, S., Medeleanu, M., Winsor, G. L., Brinkman, F. S. L., Cameron, E. E., Roos, L., Simons, E., Moraes, T. J., Mandhane, P. J., Turvey, S. E., Bolotin, S., Wright, K., McNeil, D., Patrick, D. M., Bullard, J., Langlois, M.-A., Arnold, C. R., Galipeau, Y., Pelchat, M., Doucas, N., Subbarao, P., Azad, M. B.
10.1101/2022.10.19.22281242 — Posted: 2022-10-21
Estimating the effectiveness of shielding during pregnancy against SARS-CoV-2 in New York City during the first year of the COVID-19 pandemic
Chen, S., Murphy, E. A., Pendergrass, A., Sukhu, A. C., Eng, D., Jurkiewicz, M., Mohammed, I., Rand, S., White, L. J., Hupert, N., Yang, Y. J.
10.1101/2022.10.18.22281049 — Posted: 2022-10-21
Did Risk-based or Age-based Vaccine Prioritization for Covid-19 Save More Lives?
Smits, J., Malik, A. A., Elharake, J. A., Mobarak, A. M., Omer, S. B.
10.1101/2022.10.18.22281237 — Posted: 2022-10-21
Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio
Arinaminpathy, N., Mukadi, Y. D., Bloom, A., Vincent, C., Ahmedov, S.
10.1101/2022.10.20.22281311 — Posted: 2022-10-21
Virtual care use prior to emergency department admissions during a stable COVID-19 period in Ontario, Canada
Stamenova, V., Chu, C., Borgundvaag, E., Fleury, C., Brual, J., Bhattacharyya, O., Tadrous, M.
10.1101/2022.10.20.22281298 — Posted: 2022-10-21
Changes in Treatment and Severity of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER program
Schuchard, J., Thacker, D., Webb, R., Bailey, C., Bennett, T. D., Cogen, J. D., Jhaveri, R., Jone, P.-N., Lee, G. M., Maltenfort, M., Mejias, A., Rogerson, C. M., Schulert, G. S., Mendonca, E. A., RECOVER consortium
10.1101/2022.10.19.22281256 — Posted: 2022-10-21
Fatigue presentation, severity, and related outcomes 12 weeks post-COVID-19 hospitalization
Magel, T., Meagher, E., Boulter, T., Albert, A., Tsai, M., Munoz, C., Carlsten, C., Johnston, J., Wong, A., Shah, A., Ryerson, C., McKay, R. J., Nacul, L.
10.1101/2022.10.18.22280199 — Posted: 2022-10-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).